Tags: Chemical Compound, Chemical Substance.

Abexinostat (INN formerly PCI-24781) is an experimental drug candidate for cancer treatment. It is currently under development by Pharmacyclics and is in Phase II clinical trials for B-cell lymphoma. Pre-clinical study suggests the potential for treatment of different types of cancer as well.Abexinostat exerts its effect as a histone deacetylase inhibitor.

Abexinostat.svg
IUPAC name
3-[(Dimethylamino)methyl]-N-2-[4-(hydroxycarbamoyl)phenoxy]ethyl-1-benzofuran-2-carboxamide

Loading...

This page contains content from the copyrighted Wikipedia article "Abexinostat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.